Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2009
10/22/2009US20090264631 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies
10/22/2009US20090264618 Compounds With a Branched Linker
10/22/2009US20090264528 Serine palmitoylcoa transferase (spt) inhibition by myriocin or genetic deficiency decreases cholesterol absorption
10/22/2009US20090264526 Natural ligand of G protein coupled receptor RCC356 and uses thereof
10/22/2009US20090264514 SPHINGOMYELIN SYNTHASE 2 (SMS2) DEFICIENCY ATTENUATES NFkB ACTIVATION, A POTENTIAL ANTI-ATHEROGENIC PROPERTY
10/22/2009US20090264512 exposing the sample to an aptamer that specifically binds a protein selected from Listeria monocytogenes internalin B protein and Listeria monocytogenes internalin A protein; for treating or preventing Listeria infection
10/22/2009US20090264510 Double helical oligonucleotides interfering with mRNA used as effective anticancer agents
10/22/2009US20090264507 Method of diagnosing gum disease-wound healing using single nucleotide polymorphism profiles
10/22/2009US20090264505 Methods and compositions for rnai mediated inhibition of gene expression in mammals
10/22/2009US20090264504 For modulating human immunodeficiency virus (HIV) gene expression ; nucleic acids with a pyrimidine modification; AIDS
10/22/2009US20090264501 Methods and Compositions to Inhibit P2x7 Receptor Expression
10/22/2009US20090264464 Antitumor agent for undifferentiated gastric cancer
10/22/2009US20090264455 Androgen Receptor Modulator Compounds and Methods
10/22/2009US20090264453 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
10/22/2009US20090264423 Serine-threonine protein kinase and parp modulators
10/22/2009US20090264398 Method for inducing tumor apoptosis by increasing nitric oxide levels
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264362 Influenza virus inhibiting peptides
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264360 Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors
10/22/2009US20090264356 Adenovirus 36 E4 orf 1 Gene and Protein and Their Uses
10/22/2009US20090264354 Penumbra Nucleic Acid Molecules, Proteins and Uses Thereof
10/22/2009US20090264342 Compositions and methods for antibiotic potentiation and drug discovery
10/22/2009US20090264337 Cellular GPRS-communication linked glucometer - pedometer
10/22/2009US20090264319 Method for the analysis of exclusive gene expression profile using a trace amount of sample
10/22/2009US20090264318 Analyzing Blood Type with Identification of Patient by Genotyping
10/22/2009US20090264310 Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents
10/22/2009US20090264309 Methods for Screening for Compounds that Modulate Insulin Promoter Activity
10/22/2009US20090264308 biosensor solid substrate with integrated temperature control and a method to make the same
10/22/2009US20090264307 Array-based polymorphism mapping at single nucleotide resolution
10/22/2009US20090264306 Dna methylation biomarkers in lymphoid and hematopoietic malignancies
10/22/2009US20090264305 Polynucleotide Marker Genes and their Expression, for Diagnosis of Endotoxemia
10/22/2009US20090264304 Normalized nucleic acid libraries and methods of production thereof
10/22/2009US20090264303 Polypeptides having a functional domain of interest and methods of identifying and using same
10/22/2009US20090264301 Methods utilizing differential splicing events in blood cells for the detection of pathological events
10/22/2009US20090263903 Method for determining prothrombin time
10/22/2009US20090263871 Methods and Compositions for Amplification of DNA
10/22/2009US20090263868 Nucleotide Compositions Comprising Photocleavable Markers And Methods Of Preparation Thereof
10/22/2009US20090263856 Apparatus and Method for Detecting Live Cells with an Integrated Filter and Growth Detection Device
10/22/2009US20090263855 Compositions and Methods For Preventing or Treating Inflammatory Bowel Disease
10/22/2009US20090263854 Integrated assay device and housing
10/22/2009US20090263853 High-Throughput Cell-Based CFTR Assay
10/22/2009US20090263852 Nonapoptotic forms of cell death and methods of modulation
10/22/2009US20090263851 In vivo selection system for enzyme activity
10/22/2009US20090263850 Method and system for measuring single cell mechanics using a modified scanning probe microscope
10/22/2009US20090263849 Bioprinting Three-Dimensional Structure Onto Microscale Tissue Analog Devices for Pharmacokinetic Study and Other Uses
10/22/2009US20090263848 Method for Determining the Viability of Cells in Cell Cultures
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263846 Oxygen-resistant hydrogenases and methods for designing and making same
10/22/2009US20090263845 using chemiluminescent assay by contacting the sample with choline oxidase which converts free choline to betaine and results in the production of a peroxide, and reacting the peroxide with an acridinium-9-carboxamide in the presence of a base whereupon acridone and a light signal is generated
10/22/2009US20090263844 Method and kit for quantitative determination for small, dense particle low density lipoproteins
10/22/2009US20090263843 Protein labeling with cyanobenzothiazole conjugates
10/22/2009US20090263842 Method of assessing the metastatic status of a primary tumor
10/22/2009US20090263841 assessment of non-small cell lung carcinoma; used in the early detection of lung cancer or in the surveillance of patients who undergo surgery
10/22/2009US20090263835 Genes that are Up- or Down-Regulated During Differentiation of Human Embryonic Stem Cells
10/22/2009US20090263832 Reagents for the Detection of Protein Phosphorylation in Leukemia Signaling Pathways
10/22/2009US20090263831 Ubiquitin ligase assay
10/22/2009US20090263830 Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
10/22/2009US20090263821 Ubiquitin Ligase Assays And Related Reagents
10/22/2009US20090263820 Optimization of Gene Expression Analysis using Immobilized Capture Probes
10/22/2009US20090263819 Gene and protein expression profiles associated with the therapeutic efficacy of egfr-tk inhibitors
10/22/2009US20090263818 Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by UGT1A1 enzyme or whose metabolic intermediate is metabolized by the enzyme
10/22/2009US20090263817 Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
10/22/2009US20090263816 secondary particle entrapped within a primary particle of the bead comprised of a synthetic polymer material incorporating reporter moieties, wherein the reporter moieties are quantum dots; for labelling proteins or nucleic acids, detection, diagnostics; bar-coded labelled particle libraries
10/22/2009US20090263815 Cell culture system, process for the production thereof, and the use thereof in preclinical investigation
10/22/2009US20090263814 Physiogenomic Method for Predicting Metabolic and Cardiovascular Side Effects of Thiazolidinediones
10/22/2009US20090263813 Ribonucleotide tag nucleic acid detection
10/22/2009US20090263812 Use of id4 for diagnosis and treatment of cancer
10/22/2009US20090263811 Target base discrimination method
10/22/2009US20090263810 Bisulfite conversion of dna
10/22/2009US20090263809 Methods for Identification of Bioagents
10/22/2009US20090263808 Genetic Analysis For Stratification of Cancer Risk
10/22/2009US20090263807 Optical detection field having diamond-like carbon thin film formed therein
10/22/2009US20090263806 Method for detecting chikungunya virus
10/22/2009US20090263805 Methods of identifying point mutations in a genome that affect the risk for or the age of appearance of disease
10/22/2009US20090263804 Biomarkers for aging
10/22/2009US20090263803 Mirnas differentially expressed in lymph nodes from cancer patients
10/22/2009US20090263802 Methods and compositions for efficient base calling in sequencing reactions
10/22/2009US20090263801 Phenotype-Genotype Relationship in Age-Related Macular Degeneration
10/22/2009US20090263800 Methods and compositions for diagnosing and monitoring transplant rejection
10/22/2009US20090263799 Assay for prostate cancer
10/22/2009US20090263798 Method For Identification Of Novel Physical Linkage Of Genomic Sequences
10/22/2009US20090263797 Reversible di-nucleotide terminator sequencing
10/22/2009US20090263796 Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases
10/22/2009US20090263795 DIAGNOSTIC METHODS INVOLVING DETERMINING GENE COPY NUMBERS AND SNPs IN THE FcyRII/FcyRIII GENE CLUSTER, AND PROBES FOR USE IN SUCH METHODS TO DETECT SUSCEPTIBILITY TO AND TREATMENT EFFICACY IN AUTOIMMUNE DISEASES
10/22/2009US20090263794 High Throughput Flow Through Sample Preparation Using Magnetic Beads
10/22/2009US20090263793 NOVEL METHOD FOR DIAGNOSING OF MYCOBACTERIUM Tuberculosis
10/22/2009US20090263792 measurement of the expression of specific proteins and/or their genes in skin cells and/or skin tissues, wherein the specific proteins change their expression with inflammation caused by atopic dermatitis or change their expression according to the degree of predisposition to atopic dermatitis
10/22/2009US20090263791 Chemically Cleavable 3'-O-Allyl-DNTP-Allyl-Fluorophore Fluorescent Nucleotide Analogues and Related Methods
10/22/2009US20090263790 Methods for Identifying Functionally Related Genes and Drug Targets
10/22/2009US20090263789 Method for Detecting Nucleic Acid Sequences
10/22/2009US20090263788 Efficient algorithm for pcr testing of blood samples
10/22/2009US20090263787 method for screening of infectious agents in blood
10/22/2009US20090263786 Mass spectrometric analysis method
10/22/2009US20090263785 Modified HIV-1 Peptides and Use Thereof in the Detection of Anit-HIV Antibodies
10/22/2009US20090263784 Three-dimensional structure of prostaglandin d synthase and utilization thereof
10/22/2009US20090263783 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
10/22/2009US20090263492 Diagnostic Methods and Genetic Markers for Alzheimer Disease
1 ... 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 ... 3003